Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals Inc (VRCA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $70.6M; returns 1 day -7.8%, 1 week -1.8%, 1 year -10.6%.

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company focused on developing and commercializing medications for skin diseases requiring medical interventions. Its primary revenue driver is YCANTH (cantharidin topical solution 0.7%), the first and only FDA-approved treatment for molluscum contagiosum in patients aged two years and older.

Groups VRCA belongs to

• Dermatology
• Pharmaceuticals
• Healthcare
• Biotechnology
• Commercial Stage
• Clinical Stage
• Drug Discovery
• Life Sciences
• R&D

VRCA financial model: income statement, cash flow and balance sheet